262 related articles for article (PubMed ID: 21862695)
1. The effects of ergot and non-ergot-derived dopamine agonists in an experimental mouse model of endometriosis.
Delgado-Rosas F; Gómez R; Ferrero H; Gaytan F; Garcia-Velasco J; Simón C; Pellicer A
Reproduction; 2011 Nov; 142(5):745-55. PubMed ID: 21862695
[TBL] [Abstract][Full Text] [Related]
2. Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis.
Novella-Maestre E; Carda C; Noguera I; Ruiz-Saurí A; García-Velasco JA; Simón C; Pellicer A
Hum Reprod; 2009 May; 24(5):1025-35. PubMed ID: 19189995
[TBL] [Abstract][Full Text] [Related]
3. Identification and quantification of dopamine receptor 2 in human eutopic and ectopic endometrium: a novel molecular target for endometriosis therapy.
Novella-Maestre E; Carda C; Ruiz-Sauri A; Garcia-Velasco JA; Simon C; Pellicer A
Biol Reprod; 2010 Nov; 83(5):866-73. PubMed ID: 20574053
[TBL] [Abstract][Full Text] [Related]
4. Effect of antiangiogenic treatment on peritoneal endometriosis-associated nerve fibers.
Novella-Maestre E; Herraiz S; Vila-Vives JM; Carda C; Ruiz-Sauri A; Pellicer A
Fertil Steril; 2012 Nov; 98(5):1209-17. PubMed ID: 22921078
[TBL] [Abstract][Full Text] [Related]
5. The relationship between microvessel density, proliferative activity and expression of vascular endothelial growth factor-A and its receptors in eutopic endometrium and endometriotic lesions.
Bourlev V; Volkov N; Pavlovitch S; Lets N; Larsson A; Olovsson M
Reproduction; 2006 Sep; 132(3):501-9. PubMed ID: 16940291
[TBL] [Abstract][Full Text] [Related]
6. Blocking of stromal cell-derived factor-1 reduces neoangiogenesis in human endometriosis lesions in a mouse model.
Virani S; Edwards AK; Thomas R; Childs T; Tayade C
Am J Reprod Immunol; 2013 Nov; 70(5):386-97. PubMed ID: 23650939
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy affects morphology of induced endometriotic lesions in a mouse model through alteration of proliferation and angiogenesis.
Cohen J; Naoura I; Castela M; Von N'Guyen T; Oster M; Fontaine R; Chabbert-Buffet N; Darai E; Aractingi S
Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():70-7. PubMed ID: 25461356
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol is a potent inhibitor of vascularization and cell proliferation in experimental endometriosis.
Rudzitis-Auth J; Menger MD; Laschke MW
Hum Reprod; 2013 May; 28(5):1339-47. PubMed ID: 23427233
[TBL] [Abstract][Full Text] [Related]
9. Angiogenic properties of endometrial mesenchymal stromal cells in endothelial co-culture: an in vitro model of endometriosis.
Canosa S; Moggio A; Brossa A; Pittatore G; Marchino GL; Leoncini S; Benedetto C; Revelli A; Bussolati B
Mol Hum Reprod; 2017 Mar; 23(3):187-198. PubMed ID: 28158750
[TBL] [Abstract][Full Text] [Related]
10. Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C/vascular endothelial growth factor receptor 2 expression and signaling in experimental endometriosis in vivo.
Xu H; Becker CM; Lui WT; Chu CY; Davis TN; Kung AL; Birsner AE; D'Amato RJ; Wai Man GC; Wang CC
Fertil Steril; 2011 Oct; 96(4):1021-8. PubMed ID: 21821246
[TBL] [Abstract][Full Text] [Related]
11. The Non-Ergot Derived Dopamine Agonist Quinagolide as an Anti-Endometriotic Agent.
Akyol A; Kavak E; Akyol H; Pala Ş; Gürsu F
Gynecol Obstet Invest; 2017; 82(6):527-532. PubMed ID: 27883998
[TBL] [Abstract][Full Text] [Related]
12. Combined inhibition of vascular endothelial growth factor (VEGF), fibroblast growth factor and platelet-derived growth factor, but not inhibition of VEGF alone, effectively suppresses angiogenesis and vessel maturation in endometriotic lesions.
Laschke MW; Elitzsch A; Vollmar B; Vajkoczy P; Menger MD
Hum Reprod; 2006 Jan; 21(1):262-8. PubMed ID: 16172144
[TBL] [Abstract][Full Text] [Related]
13. Quinagolide Treatment Reduces Invasive and Angiogenic Properties of Endometrial Mesenchymal Stromal Cells.
Iampietro C; Brossa A; Canosa S; Tritta S; Croston GE; Reinheimer TM; Bonelli F; Carosso AR; Gennarelli G; Cosma S; Benedetto C; Revelli A; Bussolati B
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163699
[TBL] [Abstract][Full Text] [Related]
14. [Study of tissue morphology and vascular endothelial growth factor and matrix metalloproteinase-9 gene expressions in nude mouse endometriosis model].
Wang DB; Zhang SL; Niu HY; Lu JM
Zhonghua Fu Chan Ke Za Zhi; 2004 Nov; 39(11):759-62. PubMed ID: 15634503
[TBL] [Abstract][Full Text] [Related]
15. Anti-angiogenic effects of green tea catechin on an experimental endometriosis mouse model.
Xu H; Lui WT; Chu CY; Ng PS; Wang CC; Rogers MS
Hum Reprod; 2009 Mar; 24(3):608-18. PubMed ID: 19088106
[TBL] [Abstract][Full Text] [Related]
16. Natural therapies assessment for the treatment of endometriosis.
Ricci AG; Olivares CN; Bilotas MA; Bastón JI; Singla JJ; Meresman GF; Barañao RI
Hum Reprod; 2013 Jan; 28(1):178-88. PubMed ID: 23081870
[TBL] [Abstract][Full Text] [Related]
17. ENMD-1068, a protease-activated receptor 2 antagonist, inhibits the development of endometriosis in a mouse model.
Wang Y; Lin M; Weng H; Wang X; Yang L; Liu F
Am J Obstet Gynecol; 2014 Jun; 210(6):531.e1-8. PubMed ID: 24495669
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the potential therapeutic effects of a double-stranded RNA mimic complexed with polycations in an experimental mouse model of endometriosis.
García-Pascual CM; Martínez J; Calvo P; Ferrero H; Villanueva A; Pozuelo-Rubio M; Soengas M; Tormo D; Simón C; Pellicer A; Gómez R
Fertil Steril; 2015 Nov; 104(5):1310-8. PubMed ID: 26297642
[TBL] [Abstract][Full Text] [Related]
19. A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis xenografts via antiangiogenic activity in severe combined immunodeficiency mice.
Ozawa Y; Murakami T; Tamura M; Terada Y; Yaegashi N; Okamura K
Fertil Steril; 2006 Oct; 86(4 Suppl):1146-51. PubMed ID: 16962108
[TBL] [Abstract][Full Text] [Related]
20. Animal models for anti-angiogenic therapy in endometriosis.
Edwards AK; Nakamura DS; Virani S; Wessels JM; Tayade C
J Reprod Immunol; 2013 Mar; 97(1):85-94. PubMed ID: 23432875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
